Nurse Practitioner, Adult Health · New York, NY
NPI
1548616451
Since 2016
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10 E 102nd St
New York, NY, 10029
Phone (212) 241-6756
Groups this clinician bills Medicare through
Medicare paid, 2024
$901
11 services
Medicare patients, 2024
11
Average age 76
Drug cost, 2024
$6.3M
819 prescriptions
Company payments, 2025
$1,241
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Aleksey Aronov prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 166 prescriptions and refills. In total Aleksey Aronov wrote 819 Medicare prescriptions that cost $6.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jakafi Ruxolitinib Phosphate | 166 | 170 | 42 | $2.8M |
| Hydroxyurea Generic | 89 | 139 | 27 | $1,301 |
| Inqovi Decitabine/Cedazuridine | 49 | 49 | 18 | $404K |
| Acyclovir Generic | 47 | 47 | 15 | $476 |
| Imatinib Mesylate Generic | 26 | 26 | Under 11 | $4,278 |
| Posaconazole Generic | 25 | 25 | Under 11 | $15K |
| Levofloxacin Generic | 23 | 23 | Under 11 | $228 |
| Ondansetron Odt Ondansetron | 22 | 22 | Under 11 | $114 |
| Besremi Ropeginterferon Alfa-2b-Njft | 21 | 21 | Under 11 | $329K |
| Prednisone Generic | 20 | 20 | Under 11 | $79.7 |
| Allopurinol Generic | 18 | 34 | Under 11 | $101 |
| Vonjo Pacritinib Citrate | 17 | 17 | Under 11 | $423K |
| Ojjaara Momelotinib Dihydrochloride | 16 | 20 | Under 11 | $564K |
| Pegasys Peginterferon Alfa-2a | 16 | 16 | Under 11 | $69K |
| Cefpodoxime Proxetil Generic | 16 | 16 | Under 11 | $2,219 |
Brand drugs: - claims; generic drugs: 410 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aleksey Aronov $1,241 ($1,241 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novartis Pharmaceuticals Corporation with $222.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $222 |
| Celgene Corporation BMY | 8 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $209 |
| GlaxoSmithKline, LLC. GSK | 5 | $115 |
| Blueprint Medicines Corporation SNY | 3 | $104 |
| Kite Pharma, Inc. GILD | 5 | $99.54 |
| Genzyme Corporation SNY | 3 | $88.88 |
| Rigel Pharmaceuticals, Inc. RIGL | 2 | $56.64 |
| Merck Sharp & Dohme LLC MRK | 1 | $28.41 |
| Daiichi Sankyo Inc. 4568.T | 1 | $28.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.